Department of Ophthalmology, UniversityHospital Zurich, Frauenklinikstrasse 24, 8091 Zurich, Switzerland.
BMC Ophthalmol. 2013 Sep 5;13:44. doi: 10.1186/1471-2415-13-44.
Icare PRO (ICP) is a new Rebound tonometer that is able to measure intraocular pressure (IOP) in both sitting and reclining positions. In this study, the gold standard Goldmann tonometer (GAT) was compared to ICP and Tono-Pen AVIA (TPA). Hypothesis was that repeatability of GAT is superior to ICP and TPA.
36 eyes of 36 healthy caucasian individuals, 13 male and 26 females, 17 right and 19 left eyes have been included in this prospective, randomized, cross-sectional study. The study was conducted at a single site (Dept. of Ophthalmology, University Hospital Zurich, Switzerland). Primary outcome measures were Intraclass correlation coefficients (ICC) and coefficients of variation (COV) and test-retest repeatability as visualized by Bland-Altman analysis. Secondary outcome measures were IOP in sitting (GAT, ICP and TPA) and in reclining (ICP and TPA) position.
Mean IOP measured by GAT was 14.9 ± 3.5 mmHg. Mean IOP measured by ICP was 15.6 ± 3.1 mmHg (with TPA 14.8 ± 2.7 mmHg) in sitting and 16.5 ± 3.5 mmHg (with TPA 17.0 ± 3.0 mmHg) in reclining positions. COVs ranged from 2.9% (GAT) to 6.9% (ICP reclining) and ICCs from 0.819 (ICP reclining) to 0.972 (GAT).
Repeatability is good with all three devices. GAT has higher repeatability compared to the two tested hand-held devices with lowest COVs and highest ICCs. IOP was higher in the reclining compared to the sitting position.
The study was registered to the Clinical Trials Register of the US National Institute of Health, NCT01325324.
Icare PRO(ICP)是一种新型的回弹眼压计,能够测量坐姿和仰卧位的眼压(IOP)。本研究将 Goldmann 眼压计(GAT)与 ICP 和 Tono-Pen AVIA(TPA)进行比较。假设 GAT 的可重复性优于 ICP 和 TPA。
本前瞻性、随机、交叉研究纳入了 36 名健康白种人(13 名男性和 26 名女性)的 36 只眼,17 只右眼和 19 只左眼。该研究在一个地点(瑞士苏黎世大学医院眼科)进行。主要观察指标为组内相关系数(ICC)和变异系数(COV)以及 Bland-Altman 分析显示的测试-重测重复性。次要观察指标为坐姿(GAT、ICP 和 TPA)和仰卧位(ICP 和 TPA)时的眼压。
GAT 测量的平均眼压为 14.9±3.5mmHg。坐姿时 ICP 测量的平均眼压为 15.6±3.1mmHg(TPA 为 14.8±2.7mmHg),仰卧位时为 16.5±3.5mmHg(TPA 为 17.0±3.0mmHg)。COV 范围为 2.9%(GAT)至 6.9%(ICP 仰卧位),ICC 范围为 0.819(ICP 仰卧位)至 0.972(GAT)。
三种设备的重复性均良好。与两种手持式测试设备相比,GAT 的重复性更高,COV 最低,ICC 最高。仰卧位时的眼压高于坐姿时。
该研究在美国国立卫生研究院的临床试验注册中心注册,编号为 NCT01325324。